NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$9.00
Today's Range$9.00 - $9.00
52-Week Range$2.94 - $9.05
VolumeN/A
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees158
Next Earnings DateN/A
OptionableOptionable

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

Has Raptor Pharmaceutical been receiving favorable news coverage?

News coverage about RPTP stock has trended somewhat positive on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Raptor Pharmaceutical earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the near future.

How do I buy shares of Raptor Pharmaceutical?

Shares of RPTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Raptor Pharmaceutical's official website?

The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  240 (Vote Outperform)
Underperform Votes:  256 (Vote Underperform)
Total Votes:  496
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel